Latest news with #allergyrelief
The Sun
22-07-2025
- Health
- The Sun
Thousands of hay fever sufferers will soon be prescribed a new treatment on the NHS
THOUSANDS of hay fever sufferers will soon be prescribed a new treatment on the NHS. An under-the-tongue tablet — sold under brand name Itulazax — trains the body to tolerate more pollen through exposure. And trials show it can significantly reduce the worst allergy symptoms. NHS spending watchdog Nice has now recommended it for people whose hay fever persists after basic treatment. Nice's medicines evaluations chief Helen Knight said: "This treatment will help improve people's quality of life. "Severe tree pollen allergies trap people indoors during beautiful weather and disrupt their work, education and family life. "The daily tablet offers genuine long-term relief rather than just managing symptoms." However, it only works on those with a birch pollen allergy — which is about a quarter of hay fever sufferers, estimated to be 27,000 people. The NHS in England will offer it within three months of Nice publishing its final guidance. Amena Warner, head of clinical services at Allergy UK, said: "Many people don't realise how awful it is having an itchy, runny nose, sneezing episodes or itchy, irritated eyes in the pollen season. "We frequently hear from people who avoid time outdoors, keep doors and windows shut, check pollen counts and try and minimise any exposure, which takes a significant toll on their physical and emotional wellbeing. "Nice's recommendation is so important because it provides a genuine opportunity for people to manage the root cause of their pollen allergy, offering the chance to break free from this burden and enjoy a better quality of life." hayfever recommendations from a boots pharmacist 1
Yahoo
21-07-2025
- Health
- Yahoo
Hayfever sufferers set to get new drug which will provide ‘a better quality of life'
Hayfever sufferers are set to benefit from a new treatment that will provide long-term relief for their symptoms. It has been recommended as an option on the NHS for people whose hayfever symptoms persist even after taking antihistamines or using nasal sprays, by the National Institute for Health and Care Excellence (Nice). Betula verrucosa, sold under the brand name Itulazax 12 SQ-Bet and made by Alk-Abello, is an under-the-tongue immunotherapy tablet that contains birch pollen extract. The drug trains the immune system to tolerate tree pollen over three years of daily use. Severe tree pollen allergies can cause debilitating symptoms for some people during the spring and summer months, including fatigue, breathing difficulties, inflamed sinuses, itchy, watery eyes, and vision changes. Trials show the tablet can significantly reduce the symptoms of severe hayfever by changing how the body responds to allergens. The immunotherapy works by gradually increasing the body's tolerance to tree pollen through controlled daily exposure to small amounts of pollen. Before being given the tablets, patients will require skin prick or blood tests to confirm an allergy to birch tree pollen. Nice estimates that about 27,000 people in England are expected to benefit from the recommendation. Helen Knight, director of medicines evaluation at Nice, said: 'This treatment will help improve people's quality of life. Trials show the tablet can significantly reduce the symptoms of severe hayfever by changing how the body responds to allergens ((Alamy/PA)) 'Severe tree pollen allergies trap people indoors during beautiful weather and disrupt their work, education and family life. 'The daily tablet offers genuine long-term relief rather than just managing symptoms.' According to Allergy UK, birch pollen allergy is estimated to affect about 25% of hayfever sufferers. Amena Warner, head of clinical services at Allergy UK, said: 'Many people don't realise how awful it is having an itchy, runny nose, sneezing episodes or itchy, irritated eyes in the pollen season. 'We frequently hear from people who avoid time outdoors, keep doors and windows shut, check pollen counts and try and minimise any exposure, which takes a significant toll on their physical and emotional wellbeing. 'Nice's recommendation is so important because it provides a genuine opportunity for people to manage the root cause of their pollen allergy, offering the chance to break free from this burden and enjoy a better quality of life.' Emil Stage Olsen, general manager UK and Republic of Ireland at ALK, added: 'We welcome this positive Nice recommendation, which is another meaningful advancement for the UK allergy community. 'Our focus is now on working closely with the NHS to ensure eligible patients can benefit from this first-in-class immunotherapy.' The NHS in England will provide the treatment within three months of Nice publishing its final guidance. Professor Meghana Pandit, co-medical director at NHS England, welcomed the announcement. She said: 'This innovative treatment, which will soon be rolled out on the NHS, enables patients to build up tolerance to birch tree pollen within their immune system, rather than just treating the symptoms – and we hope this will give many a new lease of life, allowing people to spend time enjoying being outside, without the discomfort allergies can bring.'
The Guardian
30-05-2025
- Health
- The Guardian
From pollen counts to pollen bombs: take our hay fever quiz to find out how much you know about this time of year
Buy Beconase now on Amazon *For the treatment of hayfever and symptomatic relief from nasal congestion, runny nose, sneezing, itchy nose, eye symptoms (such as itching, watering, redness) and associated sinus discomfort in adults aged 18 and over. Beconase Hayfever Relief for Adults 0.05% Nasal Spray contains beclometasone dipropionate. Always read the leaflet. MAT-9521
